Part 8/10:
Despite the growing body of evidence supporting the safety and efficacy of stem cell therapies, one primary challenge remains: navigating the regulatory landscape to secure FDA approvals. Dr. Hariri advocates for a balance between rigorous safety standards and the need for timely access to these innovative treatments. He argues that the myriad benefits of stem cells justify a more proactive approach to regulation.